Article
Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity.
Vaccine - 1 Apr 1995
Martinetti M, Cuccia M, Daielli C, Ambroselli F, Gatti C, Pizzochero C, Belloni C, Orsolini P, Salvaneschi L
Abstract excerpt
HLA study was performed in 9 absolute non-responder (serum titre of anti-HBsAg < 2 mIU ml-1) and 8 hyporesponder (serum antibody level between 2 and 9.9 mIU ml-1) babies who underwent, in neonatal period, HBV vaccination with Engerix B recombinant vaccine. The investigation pointed out that many...
Topics
- Alleles
- Complement C4a
- Complement C4b
- Complement Factor B
- Genome
- Haplotypes
- Hepatitis B
- Hepatitis B Antibodies
- Hepatitis B Surface Antigens
- Hepatitis B Vaccines
- Histocompatibility Antigens Class I
- Histocompatibility Antigens Class II
- Humans
- Infant
- Infant, Newborn
- Polymorphism, Genetic
- Vaccines, Synthetic